TOFACITINIB IN ULCERATIVE COLITIS: THE RELATIONSHIP BETWEEN OCTAVE INDUCTION WEEK 8 SYMPTOMATIC REMISSION AND OCTAVE SUSTAIN WEEK 52 REMISSION

Pierre Desreumaux  1     Filiz Akyüz  2     Christina Ha  3     Amira Bouzidi  4     Amel Tamzali  4     Sean Gardiner  5     Joseph Wu  6     Jerome Paulissen  5     Lucine Vuitton  7     Miguel Regueiro  8    
1 Lille University and Hospital, INFINITE, U1286, Inserm, France
2 Division of Gastroenterohepatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
3 Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, United States
4 Pfizer Inc, Paris, France
5 Pfizer Inc, New York, NY, United States
6 Pfizer Inc, Groton, CT, United States
7 University Hospital of Besançon, University Bourgogne-Franche-Comté, 25030 Besançon, France
8 Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, United States

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing